Cognitive impairment in early-stage non-demented Parkinson's disease patients
Authors:
- 11 October 2013
- journal article
- Published by Hindawi Limited in Acta Neurologica Scandinavica
- Vol. 129 (5) , 307-318
Abstract
In Parkinson's disease (PD), Parkinson's disease dementia (PDD) and Parkinson's disease-mild cognitive impairment (PD-MCI) are common. PD-MCI is a risk factor for developing PDD. Knowledge of cognition in early-stages PD is essential in understanding and predicting the dementia process. We describe the cognitive profile in early-stage PD patients with no prior clinical suspicion of cognitive impairment, depression or psychiatric disturbances, and investigate possible features distinguishing patients with cognitive deficits, defining a PD-MCI risk-profile. Single Photon Emission Computerized Tomography (SPECT) DaT-scan and neurological examination confirmed the diagnosis. Mini-mental state examination-, Addenbrooke's Cognitive Examination, Unified Parkinson's Disease Rating Scale scoring, Hoehn &Yahr/Activity of Daily Living staging and a neuropsychological test battery were applied. Mild cognitive impairment patients were identified according to modified criteria by Troster necessarily omitting subjective cognitive complaints. 80 patients, mean age 61.0 years (SD 6.6), mean duration of disease 3.4 years (SD 1.2) were included. 76 patients were neuropsychologically tested. 26 (34%) patients fulfilled modified PD-MCI criteria, 18 (69%) of these showed episodic memory deficits, 14 (54%) executive dysfunction, 13 (50%) language/praxis deficits, 12 (46%) visuospatial/constructional deficits and 9 (35%) attention/working memory deficits. Cognitive impairment was associated with higher Unified Parkinson's Disease Rating scale (UPDRS)-, bradykinesia- and rigidity scores and more symmetric distribution of symptoms, but not tremor scores. Patients with cognitive impairment were less educated. Other demographic and clinical variables were comparable. 34% of early-stage PD patients without prior clinical suspicion of cognitive impairment exhibit cognitive impairment, which is associated to disease severity, especially bradykinesia, rigidity, axial symptoms and less asymmetry of motor symptoms, even at early disease stages and when cognitive symptoms are mild.Keywords
This publication has 43 references indexed in Scilit:
- Mild cognitive impairment and cognitive-motor relationships in newly diagnosed drug-naive patients with Parkinson's diseaseJournal of Neurology, Neurosurgery & Psychiatry, 2012
- MDS task force on mild cognitive impairment in Parkinson's disease: Critical review of PD‐MCIMovement Disorders, 2011
- Inverted-U–Shaped Dopamine Actions on Human Working Memory and Cognitive ControlBiological Psychiatry, 2011
- Motor subtype and cognitive decline in Parkinson's disease, Parkinson's disease with dementia, and dementia with Lewy bodiesJournal of Neurology, Neurosurgery & Psychiatry, 2006
- Changes in motor subtype and risk for incident dementia in Parkinson's diseaseMovement Disorders, 2006
- Enhanced or Impaired Cognitive Function in Parkinson's Disease as a Function of Dopaminergic Medication and Task DemandsCerebral Cortex, 2001
- Choline acetyltransferase activity and striatal dopamine receptors in Parkinson's disease in relation to cognitive impairmentActa Neuropathologica, 2001
- A two‐fold difference in the age‐adjusted prevalences of Parkinson’s disease between the island of Als and the Faroe IslandsEuropean Journal of Neurology, 2000
- Does cognitive impairment in Parkinson's disease result from non-dopaminergic lesions?Journal of Neurology, Neurosurgery & Psychiatry, 1989
- Fluctuations in plasma dopamine level impair memory in Parkinson's diseaseNeurology, 1987